Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment

WB Theel, VD de Jong… - European Journal of …, 2024 - Wiley Online Library
Background Liver fibrosis progression is influenced by older age and cardiometabolic risk
factors such as obesity and is associated with an increased risk of cardiovascular events …

The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic …

J Lee, S Choi, SH Cho, H Yang, PS Sung, SH Bae - Diagnostics, 2024 - mdpi.com
(1) Background: Despite numerous noninvasive methods for assessing liver fibrosis,
effective ultrasound parameters remain limited. We aimed to identify easily measurable …

[HTML][HTML] An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary study

Q Wei, W Li, S He, H Wu, Q Xie, Y Peng, X Zhang - Annals of Hepatology, 2025 - Elsevier
Abstract Introduction and Objectives Advanced fibrosis is a crucial stage in the progression
of autoimmune hepatitis (AIH), where fibrosis can either regress or advance. This study aims …